Concepedia

Fei Su

FS

Statistics

Publications

71

Citations

4.4K

H-Index

29

Active since

1996

Affiliations

Harbin Medical University(Current)

Lanzhou University

First Hospital of Lanzhou University

Shanghai Jiao Tong University

Wuhan University

Fei Su is an author at Harbin Medical University specializing in medicine, cell biology, and cancer research.

ORCID

Top concepts

Publications per year

1996–2024

71

Publications

71

<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Fei Su, Amaya Virós, Carla Milagre et al. · New England Journal of Medicine · 2012 · 1K citations · Full text

RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models

Hong Yang, Brian Higgins, Kenneth Kolinsky et al. · Cancer Research · 2010 · 400 citations

, , +15

Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins

Fei Su, Robert J. Schneider · Journal of Virology · 1996 · 230 citations · Full text

, , +17

Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer

Hong Yang, Brian Higgins, Kenneth Kolinsky et al. · Cancer Research · 2011 · 214 citations · Full text

, , +17

Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma

Mario E. Lacouture, Madeleine Duvic, Axel Hauschild et al. · The Oncologist · 2013 · 213 citations · Full text

1–5 of 71